$アーテロ バイオサイエンシズ(ARTL.US)$ NEWS Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
$アーテロ バイオサイエンシズ(ARTL.US)$Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12!
1
報告
Trytosaveabitスレ主 :
Artelo Biosciences Has Completed A Pre-IND (Investigational New Drug) Meeting With The FDA Regarding The Development Plan For ART26.12; The Company Plans To File An IND Application For ART26.12 In Neuropathic Pain In 1H Of 2024
SkipperDip72954915:
Tell me if you like it. I was considering it but the support I was getting from a sales person sucked so I went a different route. Could always revisit.
アーテロ バイオサイエンシズに関するコメント
NEWS
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
2.7 million float runner trading cash levels
$5 cash levels but trading 1.80 range.
Conference tomorrow at 12 pm EST.
$アーテロ バイオサイエンシズ(ARTL.US)$
Called $SciSparc(SPRC.US)$ $スーパーコム(SPCB.US)$
$ノヴォ インテグレイティッド サイエンシ(NVOS.US)$
zoom to $0.01 soon
まだコメントはありません